Clinical Trials Logo

Filter by:
NCT ID: NCT02393573 Terminated - Insulin Resistance Clinical Trials

Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism

Start date: November 2015
Phase: N/A
Study type: Interventional

Major surgery results in a stress- induced catabolic response, marked by post-operative insulin resistance, hyperglycemia and loss of body protein, which is associated with increased morbidity, mortality and adverse outcomes. There has been a great deal of research on different approaches to optimize post-operative insulin sensitivity including hormonal and nutritional interventions, minimally invasive surgical techniques and epidural anesthesia. However, the correlation between insulin resistance and body protein loss is not well understood. Metformin is the most widely used insulin sensitizing and blood glucose-lowering drug in treatment of type 2 diabetic patients. This study will: 1) estimate the correlation between insulin resistance and body protein loss in pre-diabetic lung/colorectal resection patients; 2) investigate whether the post-operative metabolic state can be improved by the pre-operative administration of metformin; and assess the impact of metformin on surgical complications and hospital length of stay. The results of this study will provide insight into the relationship between insulin resistance and post-operative adverse events and potentially suggest a novel approach to improve outcomes using Metformin, a drug already in wide clinical use.

NCT ID: NCT02393209 Terminated - Clinical trials for Non-small Cell Lung Cancer

Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Start date: June 3, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the recommended phase 2 dose (RP2D) of TAK-117 when administered in combination with docetaxel in participants with non-small cell lung cancer (NSCLC) and to evaluate efficacy, safety, and tolerability of TAK-117 administered alone and in combination with docetaxel at the RP2D in participants with locally advanced or metastatic non-small cell lung cancer.

NCT ID: NCT02391896 Terminated - Thoracic Diseases Clinical Trials

Design and Evaluation of Mobile X-ray for Rapid and Accurate Diagnosis of Thoracic Disease

Start date: March 2015
Phase: N/A
Study type: Interventional

Computed tomography (CT) is the most accurate test for evaluating patients with thoracic disease. However, access to CT is limited due to long wait times and for the sickest patients in Hospital who cannot be transported from the ward to the CT scanner. The investigators propose to modify a standard X-ray unit to provide more detailed information of the chest such that a CT scan is not required for all patients.

NCT ID: NCT02390700 Terminated - Clinical trials for Rheumatoid Arthritis

Observational Study of Golimumab Intravenous Infusion

GO-IV
Start date: February 2015
Phase: Phase 4
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate the incidence and management of infusion reactions with Golimumab intravenous infusion.

NCT ID: NCT02388165 Terminated - Clinical trials for Staphylococcal Vaccine

Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation

STRIVE
Start date: July 2, 2015
Phase: Phase 2
Study type: Interventional

The purposes of the clinical trial are to determine whether the SA4Ag vaccine can prevent postoperative Staphylococcus aureus infections in patients who are undergoing elective spinal fusion surgery, and to evaluate the safety of SA4Ag in patients who are undergoing elective spinal surgery.

NCT ID: NCT02387229 Terminated - ATRIAL FIBRILLATION Clinical Trials

Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

BRAIN-AF
Start date: March 2015
Phase: Phase 3
Study type: Interventional

This is a prospective, multicenter, randomized, double-blinded clinical trial exploring the efficacy and safety of rivaroxaban as compared to standard of care in reducing stroke, transient ischemic attack (TIA) and neurocognitive decline, in subjects with non-valvular AF and with low risk of stroke.

NCT ID: NCT02387216 Terminated - Clinical trials for Non-Small Cell Lung Cancer

A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC

SHERLOC
Start date: February 1, 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether the combination of MM-121 plus docetaxel is more effective than docetaxel alone in regards to PFS in patients with heregulin-positive NSCLC.

NCT ID: NCT02386098 Terminated - HIV Infections Clinical Trials

Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults

Start date: July 8, 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether the combination of BMS-955176 with atazanavir (ATV) [with or without ritonavir (RTV)] and dolutegravir (DTG) is efficacious, safe, and well-tolerated in HIV-1 infected treatment experienced adults.

NCT ID: NCT02386046 Terminated - Prematurity Clinical Trials

Oxygen Saturation and Caffeine Post-Discharge

OCPDPS
Start date: February 2015
Phase:
Study type: Observational

This study aims to determine normative values of oxygen saturation in late preterm infants, and evaluate the frequency of hypoxic events in infants requiring caffeine at discharge and those not requiring it.

NCT ID: NCT02385812 Terminated - Lung Cancer Clinical Trials

Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma

Start date: January 1, 2015
Phase: Phase 2
Study type: Interventional

Asbestos defines a group of naturally occurring mineral silicate fibers which are easily inhaled, resulting in a variety of diseases of the respiratory system including lung cancer and malignant mesothelioma. Despite some advances in treatment, there has been little impact on overall survival for both lung cancer and mesothelioma in the past 20 years in great part because patients usually present with disease at an advanced and incurable stage. This study aims to develop and implement a low-dose computed tomography (LDCT) screening approach for lung cancer and mesothelioma in asbestos-exposed workers in Alberta.